ECRM_1170x120_8-1-17

Nonalcoholic fatty liver disease (NAFLD)

Noninvasive technologies help battle diabetes and NAFLD

Noninvasive technologies help battle diabetes and NAFLD

The American Liver Foundation estimates that over 30% of the U.S. population has some degree of nonalcoholic fatty liver disease (NAFLD), the most common type of liver disease in the Western world. This can impact other facets of their overall health, because NAFLD has been linked to diabetes, obesity, insulin resistance and other metabolic risk

Diabetes increases risk for liver disease

Diabetes increases risk for liver disease

Nonalcoholic fatty liver disease (NAFLD) is an asymptomatic disease that affects about 100 million Americans. Being overweight, obese or diabetic are primary risk factors for NAFLD, an umbrella term describing those liver diseases that aren’t related to alcohol consumption. Whereas consumption of too much alcohol over a period of several years is known to damage